Vaccinating Pregnant Women Protects Infants Against Severe RSV

The vaccine RSVpreF had an almost 82% efficacy against severe RSV infection in infants from birth through the first 90 days of life, according to company data.
Medscape Medical News

source https://www.medscape.com/viewarticle/985810?src=rss